Anduril will fail to hit a $132.5 billion NPM valuation on Nasdaq Private Market by September 30, 2026. That result would leave the company near today's $90.48 billion private valuation and blunt momentum around Palmer Luckey's statement that an IPO is "definitely" on the roadmap for 2026 even as A…